Released on: August 20, 2008, 1:46 am

Press Release Author: TCG Lifesciences

Industry: Healthcare

Press Release Summary: Kilo Scale Synthesis Laboratory at Chembiotek, TCG
Lifesciences, Kolkata, India

Press Release Body: New Delhi, August 20, 2008: TCG Lifesciences Limited has
commissioned its cGMP kilo scale synthesis laboratory in Kolkata at 'Chembiotek,'
its discovery research services business unit. This represents a significant new
step in establishing its fully integrated drug discovery and development research
services offerings to the global pharmaceutical and biotechnology industries. With
the aim to support its clients' developmental needs by supplying material required
for 'First-in-human' clinical studies, this facility has been designed with reactor
capacity ranging up to 200L and reaction capabilities ranging from -80 to +200
degree Celsius. High end equipment, such as Differential Scanning Calorimeter and
Reaction Calorimeter, have been installed with matching equipment like centrifuges,
jet mills, vacuum tray dryers, sifters, etc. Following 'safety through quality'
principle, the whole facility is integrated with a full scale Effluent Treatment
Plant and due care has been taken to comply with stringent Health, Safety and
Environmental ("HSE") norms. A strong quality control team has been put in place to
monitor achievement of the cGMP norms for the release of the material synthesized.

"Chembiotek is an established global leader in providing high end chemistry and
allied discovery research solutions to its customers. The addition of this cGMP
compliant kilo lab will allow us to offer developmental chemistry services which
would enable us to speedily and seamlessly transfer technology from our current
chemistry labs to the kilo lab for scale-up, process development and optimization.
This kilo lab will also serve as a robust platform for technology transfer to pilot
plant scale. Consistent with our fundamental value proposition, the kilo lab
operations will inculcate state-of-the-art science, strictly adhere to delivery time
and quality, and observe the highest ethical standards", said Swapan Bhattacharya,
Managing Director, TCG Lifesciences Limited.

"Our kilo lab would operate on a 24x7 basis with particular emphasis on efficiency,
time optimization, innovative analytical techniques and highest quality control
standards. We have taken great care in designing the labs and used the best-in-class
equipment. Keeping in mind the spectrum of reaction handling capabilities, I am sure
the lab will serve the varying needs of our existing and prospective customers. It
will support all Investigative New Drugs ("IND") enabling activities and the
manufacture of clinical trial materials under GMP conditions. Other capabilities
would include analytical method development, synthesis of impurities, metabolites
and degradation products and stability studies, as per the international guidelines.
Our in-house chemistry knowledge and experience generated over the years will help
us develop and optimize safe, eco-friendly and cost effective processes," said
Jagdish Sastry, President, Custom Synthesis and Large Scale Manufacturing.

For further information, please contact:
Anuj Kumar Boruah
Rediffusion DY&R Public Relations
Mobile: 9958372662




Web Site: http://www.tcgls.com

Contact Details: For further information, please contact:
Anuj Kumar Boruah
Rediffusion DY&R Public Relations
Mobile: (11)9958372662
email: anuj_boruah@ind.dyr.com